| Literature DB >> 26642061 |
Claudia Solari1,2, Camila Vázquez Echegaray1,2, María Soledad Cosentino1,2, María Victoria Petrone1,2, Ariel Waisman1,2, Carlos Luzzani1,2, Marcos Francia1,2, Emilly Villodre3, Guido Lenz3, Santiago Miriuka4,5, Lino Barañao1,2,5, Alejandra Guberman1,2,5,6.
Abstract
Pluripotent stem cells possess complex systems that protect them from oxidative stress and ensure genomic stability, vital for their role in development. Even though it has been reported that antioxidant activity diminishes along stem cell differentiation, little is known about the transcriptional regulation of the involved genes. The reported modulation of some of these genes led us to hypothesize that some of them could be regulated by the transcription factors critical for self-renewal and pluripotency in embryonic stem cells (ESCs) and in induced pluripotent stem cells (iPSCs). In this work, we studied the expression profile of multiple genes involved in antioxidant defense systems in both ESCs and iPSCs. We found that Manganese superoxide dismutase gene (Mn-Sod/Sod2) was repressed during diverse differentiation protocols showing an expression pattern similar to Nanog gene. Moreover, Sod2 promoter activity was induced by Oct4 and Nanog when we performed a transactivation assay using two different reporter constructions. Finally, we studied Sod2 gene regulation by modulating the expression of Oct4 and Nanog in ESCs by shRNAs and found that downregulation of any of them reduced Sod2 expression. Our results indicate that pluripotency transcription factors positively modulate Sod2 gene transcription.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26642061 PMCID: PMC4671669 DOI: 10.1371/journal.pone.0144336
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Sod2 is repressed in ESCs subjected to distinct differentiation protocols.
ESCs were cultured as described in each case. Then, RNA was extracted and the expression of the indicated genes was measured by RT-qPCR. Gene expression was normalized to the geometrical mean of Gapdh and Pgk1 expression and referred to the control condition. Results are shown as mean ± SEM of three independent experiments. (A) R1 ESCs were cultured under standard conditions in the presence of LIF (control, shown as a dashed line) or in the absence of LIF, for 4 days. * p < 0.05. (B) 46C ESCs were subjected to a neural progenitor differentiation protocol. Expression of the indicated genes was analyzed at days 0 (D0, control), 3 (D3) and 6 (D6) after the induction of differentiation. Different letters (A or B) indicate statistically significant differences between treatments. AB indicates no statistically significant difference either to A or to B (p < 0.05).
Fig 2Oct4 and Nanog induce pSod2-Luc constructions.
(A) Scheme of pSod2.1-Luc and pSod2.2-Luc constructions showing the putative binding sites for Oct4 and Nanog. (B) NIH/3T3 cells were transfected with pSod2.1-Luc or pSod2.2-Luc and with the indicated amounts of pMXs-Nanog, pMXs-Oct4 or both. Luciferase activities were measured as described in Material and Methods. Values were normalized to Renilla’s luciferase and referred to the basal condition (without the addition of any transcription factor). Results are shown as mean ± SEM of at least three independent experiments. Different letters indicate statistically significant differences between treatments (p < 0.05).
Fig 3Sod2 is repressed in R1 ESCs transfected with shRNA targeting Oct4 or Nanog.
R1 ESCs were transfected with pLKO.1-puro derived vectors targeting stem cells’ transcription factors (shOct4 or shNanog), or eGFP (shGFP, control), as indicated under each bar. Then, transfected cells were selected with puromycin for 48 hs and RNA was extracted. The expression levels of Oct4 (A), Nanog (B) or Sod2 (C) were analyzed by RT-qPCR and referred to the control. Gene expression was normalized to the geometrical mean of Gapdh and Pgk1 expression and referred to the control condition. Results are shown as mean ± SEM of at least four independent experiments. Different letters indicate statistically significant differences between treatments (p < 0.05).